• Pagaya Technologies recently closed an upsized US$800 million AAA-rated personal loan asset-backed securities transaction, PAID 2026-4, its third such upsized personal loan deal this year and part of US$40.00 billion issued across 91 ABS deals since 2018.
• The transaction, which brought in 39 institutional investors and incorporated collateral from new network partners Upstart and Achieve, underscores growing institutional acceptance of Pagaya’s AI-enabled credit and funding platform.
• Next, we’ll examine how this upsized AAA ABS deal with new partners may influence Pagaya’s investment narrative built around AI underwriting.

AI is about to change healthcare. These 38 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Pagaya Technologies Investment Narrative Recap

To own Pagaya, you need to believe its AI-driven underwriting can keep attracting lending partners and stable institutional funding, turning network volume into durable, profitable fee income. The new US$800 million upsized AAA ABS deal reinforces access to capital and broad investor appetite, which supports the near term catalyst of scaling new bank and fintech integrations. It does not, however, reduce the key risks around regulation, model performance, and dependence on major funding and lending partners.

Among recent announcements, the US$600 million PAID 2026-2 AAA personal loan ABS in April looks most relevant here, because it also pointed to strong demand for Pagaya-structured assets and added new investors. Together with PAID 2026-4 and the growing roster of partners like Upgrade, Sezzle, Experian, Upstart, and Achieve, these deals speak directly to the main catalyst of expanding network volume and funding diversity while still leaving concentration and credit cycle risks very present.

However, investors should also be aware that if a major funding partner pulls back or model performance stumbles, the impact on Pagaya could be...

Pagaya Technologies' narrative projects $1.9 billion revenue and $302.0 million earnings by 2029. This requires 13.6% yearly revenue growth and a $208.0 million earnings increase from $94.0 million today.

Uncover how Pagaya Technologies' forecasts yield a $26.90 fair value, a 78% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts already expected Pagaya to reach about US$2.0 billion of revenue and roughly US$305.8 million of earnings by 2029, but this new ABS deal may either reinforce or challenge those assumptions depending on how you weigh the upside of faster funding access against the risk that competition and regulation could still cap margins and growth.

Explore 8 other fair value estimates on Pagaya Technologies - why the stock might be worth just $20.00!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Pagaya Technologies research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Pagaya Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Pagaya Technologies' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• Uncover the next big thing with 23 elite penny stocks that balance risk and reward.
• Capitalize on the AI infrastructure supercycle with our selection of the 49 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.